Healthtech Startups

Somatus provides value-based kidney and heart care, offering individualized clinical, emotional, and social support to patients while partnering with providers and health plans to improve outcomes and lower costs. Its local, hands-on health support teams help patients manage their conditions at home.

1 investor

Luminist Labs built a non-invasive diagnostic test for early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). The company was acquired by DiscernDx in 2020.

1 investor

Lumonus builds an AI-powered oncology intelligence layer that acts as a workflow assistant for radiation oncology teams, integrating with major EMR, OIS, and TPS systems. Its products cover learning, automation, and knowledge management to speed up processes such as contouring and treatment planning while reducing errors.

1 investor

Lumoral makes a CE Class II medical device for home use that combines photobiomodulation and antibacterial (dual-light photodynamic) treatment to reduce harmful bacteria on teeth and the gum line and treat gum disease. It is sold as a consumer oral self-care product for people managing gingivitis, periodontitis, and implant care, available within Europe.

1 investor

Lumos Diagnostics develops rapid point-of-care diagnostic tests and digital reader platforms for healthcare professionals, targeting infectious and inflammatory diseases. The company offers both customized assay development services and proprietary branded diagnostic solutions.

1 investor

Lumos builds smart glasses that use a proprietary light engine and lens coating to deliver sunlike light during the day and block blue light, aimed at regulating the wearer's mood, sleep, and energy. The product targets consumers seeking to support their circadian health.

1 investor

Lumos develops sleep wellness products designed to support various lifestyles, whether for travelers, shift workers, or caregivers. The company focuses on making quality sleep accessible and compatible with modern life demands.

1 investor

LUNAC Therapeutics develops first-in-class oral and intravenous anticoagulants targeting activated Factor XII to treat and prevent thrombotic events with reduced bleeding risk. The company focuses on cardiovascular and blood coagulation therapies for patients requiring anticoagulation.

1 investor

Lunair Medical develops an implantable closed-loop system that senses respiration and stimulates the phrenic nerve to treat moderate-to-severe sleep apnea, avoiding masks, mouthpieces, and wearables. The device, currently under investigation, includes a stimulation lead, pulse generator, and titration lead to support automated therapy adjustment and patient management.

1 investor

Lura Care provides mobile, on-site health care services adapted for the elderly and people with functional diversity, delivered in care homes and day centres. Operating across Europe since 2015, it partners with over 1,000 centres to bring diagnosis and treatment to residents with mobility limitations.

1 investor

Cynosure Lutronic develops laser and radiofrequency (RF) medical devices for aesthetic and gynecologic treatments, including its XERF RF treatment. Its products are sold to practitioners, physicians, and aesthetic practice owners to expand their treatment offerings.

1 investor

LUX Infusion operates infusion centers and pharmacies that administer specialty intravenous and subcutaneous medications for patients with autoimmune disorders, neurological conditions, immune deficiencies, chronic infections, and other complex conditions. It provides clinical infusion therapy services delivered by trained care teams.

1 investor

LUX MED operates a network of private medical facilities in Poland, offering diagnostic imaging (MRI, CT, mammography, ultrasound, X-ray), laboratory testing, specialist physician consultations, and optical salons. It serves patients seeking outpatient healthcare and provides urgent medical assistance around the clock.

1 investor

LuxCreo offers an in-house 3D printing ecosystem for dental practices, combining printers, curing and washing hardware, resins, and software to produce direct-print clear aligners and other dental devices. Its workflow removes the model and thermoforming steps and includes an FDA Class II 510(k)-cleared direct-print aligner process for orthodontics, prosthodontics, and restorative dentistry.

1 investor

LVED provides a digital platform for creating, managing, and executing estate plans with secure storage for legal documents, digital assets, and final messages. The platform serves individuals seeking to organize and transfer their financial, emotional, and digital legacies to designated beneficiaries.

1 investor

LXE Hearing is the parent company of hearing-technology brands Eargo, Lexie Hearing, and hearX, offering direct-to-consumer and over-the-counter hearing aids plus tools for detecting and diagnosing hearing loss. The company has begun winding down its US operations.

1 investor

Lydus Medical develops surgical devices for anastomosis procedures in microsurgery, combining clinical insight with engineering to make these operations faster and more reliable. The company was founded within Sanara Ventures based on a clinical need identified in the microsurgery operating room.

1 investor

LyfeMD is a virtual clinic offering personalized, evidence-based guidance on nutrition, mental wellness, and movement for patients managing IBD (Crohn's/colitis) and inflammatory arthritis. It provides nutrition planning, mental wellness support, health coaching, and patient education to complement patients' existing medical treatment.

1 investor

LyfPlus provides digital health solutions for hospitals, helping them optimize operations and improve service quality by modernizing paper-based health infrastructure.

1 investor

LyGenesis is a clinical-stage cell therapy company that uses a patient's own lymph nodes as bioreactors to grow functioning ectopic organs. Its allogeneic cell therapies target diseases including end stage liver disease, end stage renal disease, Type 1 diabetes, and aging of the thymus.

1 investor

LymphaTouch is a Finnish health technology company that manufactures a medical device combining negative pressure and mechanical vibration for manual therapy applications including edema management, soft tissue mobilization, scar therapy, and pain management.

1 investor

Lync Bio develops fourth-generation SMART ADC (antibody-drug conjugate) technology for oncology, leveraging proprietary dual-target conjugate design and payload engineering to improve tumor coverage, cellular response, and manufacturability.

1 investor

Lynd Clinical operates a network of clinical research sites in underserved rural and community markets, using technology and local partnerships to expand patient access to clinical trials. The company combines on-the-ground site development with AI-enabled infrastructure to make research populations more representative and accessible to pharmaceutical sponsors.

1 investor

Lyngo builds AI phone answering systems designed specifically for healthcare clinics, automating call handling and appointment booking while maintaining human oversight for patient care. The service operates 24/7 to reduce administrative burden on front desk teams and support clinic operations globally.

1 investor